Fundraising Fox

Kelsie Biotech Chemicals R&D

Englewood, US · Founded 2019 · Delaware corporation · 2 known investors

kel-sie.com ↗

KelSie Biotech is a biotechnology company developing and commercializing drug-delivery technologies licensed from Sievers Biotech, including a Bubble Drying Process, sublingual wafers, and dry powder inhalable products. The company holds worldwide rights to formulate, sell, and sublicense finished products based on this technology and intellectual property.

BiotechHealthtechMedical Devices

Founders & leadership

Kelsie Biotech Chemicals R&D was founded in 2019 by Cameron F. Keluche.

CF
Cameron F. KeluchePresident & CEO
CS
Christie SpencerSecretary and Chief Financial Officer of Issuer
WJ
William J. GreenNamed on SEC filing
LS
Linda S. SonntagNamed on SEC filing
BK
Ben KaantaExecutive Chairperson
SA
Steven AddisChief Marketing Officer
SW
Shon WilliamsChief Revenue Officer

Board

JH
Jeffrey HowardBoard directorManaging Partner at Salveo Capital
MG
Michael GruberBoard directorManaging Partner at Salveo Capital

Investors · 2

7thirtyBoulder · $100K – $1M
Salveo CapitalNorthbrook

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 2 rounds · 2019–2021

▶$1.3MraisedApr 2021 · 16 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GruberDirector
  • Jeffrey HowardDirector
  • Ben KaantaExecutive Officer, Director
  • Cameron F. KelucheExecutive Officer, Director
  • Linda SonntagDirector
Offering amount
$2M
Amount sold
$1.3M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2019 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christie SpencerExecutive Officer
  • Cameron F. KelucheExecutive Officer, Director
  • Jeffrey HowardDirector
  • William J. GreenDirector
  • Linda S. SonntagDirector
  • Michael GruberDirector
Offering amount
$5M
Amount sold
$2M
First sale
May 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.